BNTX logo

BioNTech SE (BNTX) EBIT

annual EBIT:

-$719.87M-$2.01B(-155.69%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BNTX annual earnings before interest & taxes is -$719.87 million, with the most recent change of -$2.01 billion (-155.69%) on December 31, 2024.
  • During the last 3 years, BNTX annual EBIT has fallen by -$18.38 billion (-104.08%).
  • BNTX annual EBIT is now -104.08% below its all-time high of $17.66 billion, reached on December 31, 2021.

Performance

BNTX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

quarterly EBIT:

-$432.99M-$751.71M(-235.85%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX quarterly earnings before interest & taxes is -$432.99 million, with the most recent change of -$751.71 million (-235.85%) on March 1, 2025.
  • Over the past year, BNTX quarterly EBIT has dropped by -$77.70 million (-21.87%).
  • BNTX quarterly EBIT is now -107.68% below its all-time high of $5.64 billion, reached on March 31, 2022.

Performance

BNTX quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM EBIT:

-$790.72M-$77.70M(-10.90%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX TTM earnings before interest & taxes is -$790.72 million, with the most recent change of -$77.70 million (-10.90%) on March 1, 2025.
  • Over the past year, BNTX TTM EBIT has dropped by -$955.00 million (-581.33%).
  • BNTX TTM EBIT is now -103.72% below its all-time high of $21.24 billion, reached on March 31, 2022.

Performance

BNTX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

BNTX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-155.7%-21.9%-581.3%
3 y3 years-104.1%-107.7%-103.7%
5 y5 years-261.9%-640.3%-277.9%

BNTX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-104.1%at low-107.7%+49.6%-103.7%at low
5 y5-year-104.1%at low-107.7%+49.6%-103.7%at low
alltimeall time-104.1%at low-107.7%+49.6%-103.7%at low

BNTX EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$432.99M(-235.9%)
-$790.72M(+10.9%)
Dec 2024
-$719.87M(-155.7%)
$318.72M(+73.8%)
-$713.02M(+127.2%)
Sep 2024
-
$183.34M(-121.3%)
-$313.87M(+26.8%)
Jun 2024
-
-$859.79M(+142.0%)
-$247.44M(-250.6%)
Mar 2024
-
-$355.29M(-149.5%)
$164.28M(-87.5%)
Dec 2023
$1.29B(-90.6%)
$717.87M(+187.4%)
$1.31B(-65.9%)
Sep 2023
-
$249.77M(-155.7%)
$3.84B(-36.6%)
Jun 2023
-
-$448.06M(-156.6%)
$6.06B(-29.2%)
Mar 2023
-
$791.24M(-75.6%)
$8.55B(-36.2%)
Dec 2022
$13.68B(-22.5%)
$3.25B(+31.6%)
$13.40B(-13.0%)
Sep 2022
-
$2.47B(+20.5%)
$15.41B(-16.5%)
Jun 2022
-
$2.05B(-63.7%)
$18.44B(-13.2%)
Mar 2022
-
$5.64B(+7.3%)
$21.24B(+20.8%)
Dec 2021
$17.66B
$5.25B(-4.6%)
$17.59B(+39.8%)
DateAnnualQuarterlyTTM
Sep 2021
-
$5.50B(+13.5%)
$12.58B(+84.1%)
Jun 2021
-
$4.85B(+144.9%)
$6.83B(+262.6%)
Mar 2021
-
$1.98B(+705.3%)
$1.88B(-1325.1%)
Dec 2020
-$164.22M(-17.4%)
$245.85M(-201.6%)
-$153.82M(-66.9%)
Sep 2020
-
-$242.07M(+144.2%)
-$464.22M(+82.0%)
Jun 2020
-
-$99.12M(+69.5%)
-$255.05M(+21.9%)
Mar 2020
-
-$58.49M(-9.4%)
-$209.23M(+6.5%)
Dec 2019
-$198.93M(+266.7%)
-$64.55M(+96.3%)
-$196.47M(+47.6%)
Sep 2019
-
-$32.89M(-38.3%)
-$133.11M(+6.5%)
Jun 2019
-
-$53.30M(+16.5%)
-$124.97M(+74.4%)
Mar 2019
-
-$45.73M(+3738.9%)
-$71.67M(+176.3%)
Dec 2018
-$54.25M(-43.8%)
-$1.19M(-95.2%)
-$25.94M(+4.8%)
Sep 2018
-
-$24.75M
-$24.75M
Dec 2017
-$96.52M
-
-

FAQ

  • What is BioNTech SE annual earnings before interest & taxes?
  • What is the all time high annual EBIT for BioNTech SE?
  • What is BioNTech SE annual EBIT year-on-year change?
  • What is BioNTech SE quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for BioNTech SE?
  • What is BioNTech SE quarterly EBIT year-on-year change?
  • What is BioNTech SE TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for BioNTech SE?
  • What is BioNTech SE TTM EBIT year-on-year change?

What is BioNTech SE annual earnings before interest & taxes?

The current annual EBIT of BNTX is -$719.87M

What is the all time high annual EBIT for BioNTech SE?

BioNTech SE all-time high annual earnings before interest & taxes is $17.66B

What is BioNTech SE annual EBIT year-on-year change?

Over the past year, BNTX annual earnings before interest & taxes has changed by -$2.01B (-155.69%)

What is BioNTech SE quarterly earnings before interest & taxes?

The current quarterly EBIT of BNTX is -$432.99M

What is the all time high quarterly EBIT for BioNTech SE?

BioNTech SE all-time high quarterly earnings before interest & taxes is $5.64B

What is BioNTech SE quarterly EBIT year-on-year change?

Over the past year, BNTX quarterly earnings before interest & taxes has changed by -$77.70M (-21.87%)

What is BioNTech SE TTM earnings before interest & taxes?

The current TTM EBIT of BNTX is -$790.72M

What is the all time high TTM EBIT for BioNTech SE?

BioNTech SE all-time high TTM earnings before interest & taxes is $21.24B

What is BioNTech SE TTM EBIT year-on-year change?

Over the past year, BNTX TTM earnings before interest & taxes has changed by -$955.00M (-581.33%)
On this page